Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco

By Jon Dobson / Email the Author / “The Gray Sheet” Jul. 9, 2007, Vol. 33, No. 028
Business / Word Count: 1464 / Article # 01330280005

Executive Summary

Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International

Purchase this Article

$85.00 Buy Now

For $85.00, purchase this 1464-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to “The Gray Sheet” will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel

Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco

Executive Summary

Purchase this Article

Already a Subscriber?

Questions?

Related Articles: 13

Elsevier Business Intelligence Publications

Offers & Events

Topics Covered in this Article

Email Article